Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Steger

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Digestion|January 1, 1994
Folate absorption in Crohn's diseaseG G Steger, R M Mader, H Vogelsang, et al.
Archives of Environmental Health|July 1, 1996
Exposure of oncologic nurses to methotrexate in the treatment of osteosarcomaR M Mader, B Rizovski, G G Steger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Instability of the anticancer agent etoposide under in vitro culture conditionsR M Mader, G G Steger, K Moser, et al.
Journal of Internal Medicine|June 1, 1993
GM-CSF in the treatment of a patient with severe methotrexate intoxicationG G Steger, R M Mader, M F Gnant, et al.
British Journal of Cancer|February 7, 2001
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequenceR Sedivy, B Wolf, M Kalipciyan, et al.
International Journal of Cancer|December 17, 1997
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitroT Brodowicz, C Wiltschke, A C Budinsky, et al.
Oncology Research|January 1, 1996
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidineG Findenig, R M Mader, M Fritzer-Szekeres, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Benefit of interferon-alpha2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virusG J Locker, R M Mader, B Steiner, et al.
Wiener Klinische Wochenschrift|December 10, 1999
[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)]C Wenzel, M Schmidinger, G J Locker, et al.
British Journal of Clinical Pharmacology|September 1, 1995
Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancerR M Mader, G G Steger, B Rizovski, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Digestion|January 1, 1994
Folate absorption in Crohn's diseaseG G Steger, R M Mader, H Vogelsang, et al.
Archives of Environmental Health|July 1, 1996
Exposure of oncologic nurses to methotrexate in the treatment of osteosarcomaR M Mader, B Rizovski, G G Steger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Instability of the anticancer agent etoposide under in vitro culture conditionsR M Mader, G G Steger, K Moser, et al.
Journal of Internal Medicine|June 1, 1993
GM-CSF in the treatment of a patient with severe methotrexate intoxicationG G Steger, R M Mader, M F Gnant, et al.
British Journal of Cancer|February 7, 2001
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequenceR Sedivy, B Wolf, M Kalipciyan, et al.
International Journal of Cancer|December 17, 1997
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitroT Brodowicz, C Wiltschke, A C Budinsky, et al.
Oncology Research|January 1, 1996
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidineG Findenig, R M Mader, M Fritzer-Szekeres, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Benefit of interferon-alpha2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virusG J Locker, R M Mader, B Steiner, et al.
Wiener Klinische Wochenschrift|December 10, 1999
[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)]C Wenzel, M Schmidinger, G J Locker, et al.
British Journal of Clinical Pharmacology|September 1, 1995
Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancerR M Mader, G G Steger, B Rizovski, et al.
Pageof 7